Cargando…

Differential impact of BRAFV600E isoforms on tumorigenesis in a zebrafish model of melanoma

BRAFV600E comes as two main splicing variants. The well-studied ref isoform and the recently discovered X1 isoform are co-expressed in cancer cells and differ in terms of 3’UTR length and sequence, as well as C-term protein sequence. Here, we use a melanoma model in zebrafish to study the role playe...

Descripción completa

Detalles Bibliográficos
Autores principales: De Paolo, Raffaella, Sarti, Samanta, Bernardi, Sara, Cucco, Francesco, Tavosanis, Andrea, Pitto, Letizia, Poliseno, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314448/
https://www.ncbi.nlm.nih.gov/pubmed/37393328
http://dx.doi.org/10.1186/s13578-023-01064-w
Descripción
Sumario:BRAFV600E comes as two main splicing variants. The well-studied ref isoform and the recently discovered X1 isoform are co-expressed in cancer cells and differ in terms of 3’UTR length and sequence, as well as C-term protein sequence. Here, we use a melanoma model in zebrafish to study the role played by each isoform in larval pigmentation, nevi formation, and their progression into melanoma tumours. We show that both BRAFV600E-ref and BRAFV600E-X1 proteins promote larval pigmentation and nevi formation, while melanoma-free survival curves performed in adult fish indicate that BRAFV600E-ref protein is a much stronger melanoma driver that BRAFV600E-X1 protein. Crucially, we also show that the presence of the 3’UTR suppresses the effect of ref protein. Our data highlight the necessity to undertake a systematic study of BRAFV600E isoforms, in order to uncover the full spectrum of their kinase-(in)dependent and coding-(in)dependent functions, hence to develop more informed strategies for therapeutic targeting. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13578-023-01064-w.